Navigation Links
Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis
Date:8/29/2014

Burnt Hills, NY (PRWEB) August 29, 2014

Local veterinarian, Dr. Keith Clement, and his team at Burnt Hills Veterinary Hospital are seeking candidates to participate in an investigational study of donor stem cells for dogs with osteoarthritis. The ultimate goal of this study is to determine if a single injection of donor stem cells into one or two arthritically affected joints can help reduce pain and inflammation in the treated joints.

Candidates for the current investigational study must be older than nine months, weigh more than five and a half pounds, have osteoarthritis of only one or two leg joints, have had pain or lameness for at least three months, and must not have cancer. Joints that will be included in the study and injected under anesthesia include hips, stifles, shoulders, and elbows. Dogs that may be considered must be in good health and undergo a diagnostic work up before qualifying for the study. Dogs that qualify for the study may not have had previous stem cell therapy of any kind.

In 2008, Dr. Clement was credentialed with Vet-Stem, Inc. in Regenerative Veterinary Medicine for arthritis, ligament and tendon injuries, and joint issues with stem cell therapy. To date he has treated over 80 patients. In May 2011 Dr. Clement presented a paper at the 2nd Annual North American Veterinary Regenerative Medicine Association Conference and November 2011 he spoke on stem cell therapy at the Illinois Veterinary Medical Association Conference.

For information about the study, Dr. Clement can be reached at 518-399-5213.

About Vet-Stem, Inc.
Since its formation in 2002, Vet-Stem, Inc. has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem pioneered the use of regenerative stem cells for horses, dogs, and cats. In 2004 the first horse was treated with Vet-Stem Regenerative Cell Therapy. Ten years later Vet-Stem celebrated its 10,000th animal treated. As animal advocates, veterinarians, veterinary technicians, and cell biologists, the team at Vet-Stem tasks themselves with the responsibility of discovering, refining, and bringing to market innovative medical therapies that utilize the body’s own healing and regenerative cells.

Read the full story at http://www.prweb.com/releases/keith-clement/burnt-hills/prweb12127771.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
2. Pinnaclife Animal Health Features Seal N Heal Wound Shield in New Veterinary Dermatologist Tested and Approved Product Line!
3. Veterinary Bioscience Institute (VBI) and a-tune software, Inc. Partnership
4. The Veterinary Bioscience Institute's 2012 Year in Review
5. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
6. The Veterinary Bioscience Institute Announces its January 2013 Webinar Schedule
7. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
8. The Veterinary Bioscience Institute Partners with LabRoots to Produce Laboratory Animal Science BioConference Live
9. The Veterinary Bioscience Institute Announces a Mouse Surgery Webinar Series
10. The Veterinary Bioscience Institute Announces its Roux-en-Y Gastric Bypass Surgery Model in Rodents
11. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... (PRWEB) , ... January 12, ... ... disposable devices with short response times capable of performing routine electrochemical biosensing ... disposable screen-printed electrodes provide fast, sensitive detection and quantification of various analytes ...
(Date:1/12/2017)... 12, 2017   Protein Sciences Corporation , ... Flublok Influenza Vaccine ®, announced today that ... good safety results and induced strong neutralizing antibodies ... product is expected to advance into human clinical ... the Institute of Technology in Immunobiologicals of the ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase ... show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ ... treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit from ...
(Date:1/11/2017)... -- Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic ... will be attending the 47th Annual World Economic Forum ... 17-20, 2017. This will be Dr. Mehling,s fifth year ... this year,s forum is Responsive and Responsible Leadership; over ... for fostering greater social inclusion and human development. One-third ...
Breaking Biology Technology:
(Date:12/7/2016)... to a new market research report "Emotion Detection and Recognition Market by Technology ... End User, And Region - Global Forecast to 2021", published by MarketsandMarkets, the ... USD 36.07 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 2016   Avanade is helping Williams Martini ... in history, exploit biometric data in order to critically ... the competitive edge against their rivals after their impressive, ... Avanade has worked with Williams during the 2016 season ... (heart rate, breathing rate, temperature and peak acceleration) for ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
Breaking Biology News(10 mins):